There is circumstantial evidence implicating reactive oxygen species (ROS) in the highly ordered temporal and spatial regulation of expression of the Cat and Sod antioxidant genes during seed development and germination in maize. In order to understand and provide experimental data for the regulatory role of ROS, the expression patterns of the Cat1, Cat2, Cat3, GstI, Sod3, Sod4, and Sod4A genes, as well as catalase (CAT) and superoxide dismutase (SOD) activity responses, were examined after treatments with ROS-generating xenobiotics in developing and germinated maize scutella. CAT and SOD activities increased at both stages in response to each xenobiotic examined in a dose-dependent and stage-specific manner. Individual Cat gene expression patterns were co-ordinated with isozyme patterns of enzymatic activity in scutella of developing seeds. This was not observed in germinated seeds where, although Cat1 expression was highly induced by ROS, there was not a similar increase of enzymatic CAT1 activity, suggesting the involvement of post-transcriptional regulation. Enhanced enzyme activities were synchronous with increases in steady-state transcript levels of specific Sod genes. The steady-state transcript level of GstI was elevated in all samples examined. Gene expression responses derived from this study along with similar results documented in previous reports were subjected to cluster analysis, revealing that ROS-generating compounds provoke similar effects in the expression patterns of the tested antioxidant genes. This could be attributable to common stress-related motifs present in the promoters of these genes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/jxb/erl292 | DOI Listing |
Acta Neuropathol Commun
January 2025
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Recent genomic studies have allowed the subdivision of intracranial ependymomas into molecularly distinct groups with highly specific clinical features and outcomes. The majority of supratentorial ependymomas (ST-EPN) harbor ZFTA-RELA fusions which were designated, in general, as an intermediate risk tumor variant. However, molecular prognosticators within ST-EPN ZFTA-RELA have not been determined yet.
View Article and Find Full Text PDFJ Transl Med
January 2025
State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai, 200120, China.
Background: Dilated cardiomyopathy (DCM) is one of the most common causes of heart failure. Infiltration and alterations in non-cardiomyocytes of the human heart involve crucially in the occurrence of DCM and associated immunotherapeutic approaches.
Methods: We constructed a single-cell transcriptional atlas of DCM and normal patients.
Mol Cancer
January 2025
Department of Hematology, Qilu Hospital of Shandong University, No.117, West of Wenhua Road, Jinan, Shandong, 250012, People's Republic of China.
Background: Drug resistance and immune escape continue to contribute to poor prognosis in AML. Increasing evidence suggests that exosomes play a crucial role in AML immune microenvironment.
Methods: Sanger sequencing, RNase R and fluorescence in situ hybridization were performed to confirm the existence of circ_0006896.
Breast Cancer Res Treat
January 2025
University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Purpose: To identify needs of metastatic breast cancer patients prior to starting a new systemic treatment.
Methods: Fifty patients with newly diagnosed, recurrent, or progressive metastatic breast cancer completed an electronic survey which included patient-reported outcome measures of function (PROMIS Cancer Function Brief 3D profile), quality of life (FACT-G), exercise (Godin Leisure-Time exercise questionnaire), and diet (REAP-S); demographic information; and self-reported use of or referral to specific resources at the cancer center prior to beginning a new systemic oncologic treatment.
Results: Prior to starting a new treatment for metastatic breast cancer, patients reported mild functional impairment (PROMIS Cancer Function Brief 3D profile mean score:42.
Bull Exp Biol Med
January 2025
Department of Laboratory Medicine, Putian University, Putian, China.
The mechanism of Hespintor (a protein of serpin family) inhibitory action on the growth of inoculated hepatocellular carcinoma was studied in a model of human hepatoma in nude mice by using on long-noncoding RNA (lncRNA) sequencing. Two days after tumor transplantation, Hespintor or normal saline was injected into the caudal vein at a dose of 15 μg/kg (2 times a week over 4 weeks). The tumors were isolated in 4 weeks after subcutaneous injection of human hepatoma MHCC97-H cells.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!